Two concurrent outbreaks of hepatitis A highlight the risk of infection for non-immune travellers to Morocco, January to June 2018
| Autor: | Julie Figoni, Luise Müller, Sofie Midgley, Ingrid H M Friesema, Jürgen J. Wenzel, Carmen Varela, Ana Avellón, Martyna Gassowski, Siew Lin Ngui, Koye Balogun, Josefine Lundberg Ederth, Mirko Faber, Kai Michaelis, Lina Mouna, Harry Vennema, Lena Sundqvist, James Plunkett, Sofie Gillesberg Lassen |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Adult Male food-borne infections Epidemiology 030106 microbiology 610 Medizin Food-borne infections imported viral diseases Disease Outbreaks 03 medical and health sciences 0302 clinical medicine Immune system Virology Environmental health hepatitis A virus Medicine Humans 030212 general & internal medicine ddc:610 Travel business.industry Risk of infection Vaccination Public Health Environmental and Occupational Health Outbreaks Hepatitis A Outbreak medicine.disease Hepatitis a virus Molecular analysis Europe Morocco outbreaks Female Hepatitis A virus business 610 Medizin und Gesundheit Imported viral diseases human activities Rapid Communication |
| Zdroj: | Repisalud Instituto de Salud Carlos III (ISCIII) Eurosurveillance |
| Popis: | From January to June 2018, two ongoing hepatitis A outbreaks affected travellers returning from Morocco and cases in Europe without travel history, resulting in 163 patients in eight European countries. Most interviewed travel-related cases were unaware of the hepatitis A risk in Morocco. Molecular analysis revealed two distinct hepatitis A virus (HAV) strains (subgenotype IA DK2018_231; subgenotype IB V18-16428). Vaccination recommendations should be emphasised to increase awareness among non-immune travellers to Morocco and HAV-endemic countries. First, we thank the European Centre for Disease Prevention and Control (ECDC)’s Food- and Waterborne Diseases and Zoonoses team, particularly Ettore Severi and Johanna Takkinen for their support of this joint investigation. We also thank Lelia Thornton, HSE - Health Protection Surveillance Centre, Dublin, Ireland for sharing information on the Irish hepatitis A patient. Moreover, we greatly acknowledge the work of local and state health departments for their support of epidemiological investigations and molecular surveillance. Sí |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|